News
News

The latest updates from AFAR.

AFAR in the News: Scientific Director Steven Austad interview in International Innovations Interview

Apr 15
2015

AFAR in the News: Scientific Director Steven Austad interview in International Innovations Interview

  The April 2015 issue of International Innovations Journal features an interview with AFAR’s Scientific Director, Steven Austad, Ph.D. In the interview, Dr. Austad dispells common myths about aging research, discusses major trends such as geroscience and translational research, and provides an update on his personal research. Download the complete interview as a PDF here or view the entire International Innovations issue here. International Innovations has featured several interviews with AFAR leaders, including  Board President Harvey Jay Cohen, M.D., and Executive Director Stephanie Lederman. Dr. Steven Austad is a Professor in and Chairman of the…


View MoreREAD MORE


Grantee in the News: Malaz Boustani Weighs in on Study Connecting Dementia and Weight

Apr 10
2015

Grantee in the News: Malaz Boustani Weighs in on Study Connecting Dementia and Weight

On April 10th, 2015, two-time grantee Dr. Malaz Boustani lent  his expert opinion to a U.S. News and Reports’ HealthDay piece on new research showing a potential correlation between weight and the onset of dementia. In a study of nearly 2 million adults in the UK, researchers found that individuals who were overweight or obese were 30% less likely to develop dementia over the next 15 years. Dr Boustani noted that while more research needs to be done before a cause and effect relationship can be determined, “if a biological mechanism can be found to support these findings, it…


View MoreREAD MORE


Grantee in the News: Reisa Sperling Leads Alzheimer’s Clinical Trial

Mar 27
2015

Grantee in the News: Reisa Sperling Leads Alzheimer’s Clinical Trial

On March 27th, 2015, The Boston Globe reported on a new clinical trial led by 2003 Beeson Scholar Reisa Sperling, MD, MMSc, to test a drug that may help prevent Alzheimer’s disease. In the trial, researchers will test whether a drug, referred to as A4, can prevent Alzheimer’s disease in people who have no symptoms but are at risk. Dr. Sperling is looking to recruit 1,000 adults between the ages of 65-85, particularly people of color. Reisa Sperling, MD, MMSc, is the Director, Center for Alzheimer's Research and Treatment & Co-Director, Neuroimaging Core at the Massachusetts Alzheimer'…


View MoreREAD MORE


AFAR in the News: Wall Street Journal article spotlights AFAR-supported “TAME” study

Mar 17
2015

AFAR in the News: Wall Street Journal article spotlights AFAR-supported “TAME” study

On March 17, 2015, AFAR and several of our experts were  featured in a Wall Street Journal article, “To Grow Old Without Disease.” Prominently featured on the cover of the Personal Journal section, the article examines the Targeting Aging with Metformin or “TAME” trial, which AFAR has helped plan and fund, and cites project leader and AFAR Deputy Scientific Director, Dr. Nir Barzilai as well as AFAR Board Members Dr. James Kirkland and Dr. S. Jay Olshansky. The goal of the project is to implement a clinical study testing metformin, an FDA approved drug that researchers’…


View MoreREAD MORE


Board Member in the News: Medical Officer Richard Besdine’s latest Column explores Elder Abuse

Mar 17
2015

Board Member in the News: Medical Officer Richard Besdine’s latest Column explores Elder Abuse

In his latest Huffington Post blog, AFAR Medical Officer Richard W. Besdine, M.D., draws attention to the relationship between elder abuse and health, particularly as a concern for geriatric professionals and personal caregivers. Defining elder abuse as “the physical, psychological or sexual harm, neglect (self-neglect or by a caregiver) or financial exploitation of vulnerable older people,”  Dr. Besdine states “that elder abuse has devastating and far-reaching health consequences, and triples the risk of premature death, compared to a group of older adults with similar medical problems…” The article also includes insights from Board…


View MoreREAD MORE




BACK TO TOPBACK TO TOP